copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Short-term vs conventional glucocorticoid therapy in acute . . . Objective: To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids
Short term versus standard glucocorticoid therapy in acute . . . Semantic Scholar extracted view of "Short term versus standard glucocorticoid therapy in acute exacerbations of COPD The “REDUCE*” randomized noninferiority trial (*Reduction in the Use of Corticosteroids in Exacerbated COPD)" by J Leuppi et al
Short-term vs conventional glucocorticoid therapy in acute . . . To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids
ACUTE - Anschutz Medical Campus Objective To investigate whether a short-term (5 days) systemic glucocorticoid treat-ment in patients with COPD exacerbation is noninferior to conventional (14 days) treat-ment in clinical outcome and whether it decreases the exposure to steroids
Short-Term Versus Conventional Glucocorticoid Therapy in Acute . . . The authors concluded that this study supports the use of a 5-day glucocorticoid treatment in acute exacerbations of COPD due to noninferiority to a conventional treatment course and reduction in glucocorticoid exposure
Short-term vs conventional glucocorticoid therapy in acute . . . To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids
Short versus conventional term glucocorticoid therapy in acute . . . The aim of this trial is to demonstrate non-inferiority of a five-day compared to a 14-day course of systemic glucocorticoids with respect to COPD outcome, thereby significantly reducing steroid exposure and side effects in patients with COPD exacerbations
Medline ® Abstract for Reference 37 of COPD exacerbations . . . - UpToDate OBJECTIVE To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids